期刊文献+

老年脓毒症患者免疫调理治疗前后T淋巴细胞亚群的变化 被引量:3

Changes of lymphocyte subsets in elderly patients with sepsis before and after immune modulation therapy
下载PDF
导出
摘要 目的:研究老年脓毒症患者免疫调理治疗前后T淋巴细胞亚群的变化,为脓毒症的治疗提供依据。方法:76例65岁以上的老年脓毒症患者随机分为对照组,包括常规治疗组(常规治疗,n=38)和治疗组(常规治疗基础上每日加用1.6mg胸腺肽α1皮下注射,治疗15d,n=38);另选20例65岁以上健康老年人作为正常组。分别在用药前后测定各组研究对象淋巴细胞亚群比率。结果:治疗前,与正常组比较,对照组和治疗组患者T淋巴细胞(CD3+)、辅助性T淋巴细胞(CD4+Th)、CD4+Th亚群1(Th1)、B淋巴细胞(CD19+)、自然杀伤细胞(NK)比率、辅助性T淋巴细胞与抑制性T淋巴细胞比值(CD4+/CD8+)明显降低(P<0.01);调节性T淋巴细胞(Treg)和CD8+比率升高(P<0.05或P<0.01),CD4+Th亚群2(Th2)比率有升高趋势,但组间比较差异无统计学意义(P<0.05)。对照组和治疗组患者各项指标比较差异均无统计学意义(P>0.05)。治疗后,与对照组比较,治疗组患者血浆CD3+、CD4+Th和Th1比率明显升高(P<0.05或P<0.01),CD4+/CD8+比值、CD19+和NK细胞比率有升高趋势(P>0.05);CD8+细胞比率下降(P<0.05),Th2和Treg细胞比率有下降趋势(P>0.05)。结论:与健康老年人比较,老年脓毒症患者淋巴细胞总数减少,淋巴细胞亚群比例失衡。胸腺肽α1能增加老年脓毒症患者淋巴细胞总数,改善淋巴细胞亚群比例失衡。 Objective To investigate the changes of lymphocyte subsets in the elderly patients with severe sepsis before and after immune modulation therapy,and to provide the basis for curing the disease.Methods 76 patients older than 65 years were enrolled and randomly divided into control group(n=38)and treatment group(n=38).All patients were received conventional therapy and the patients in treatment group were received 1.6mg thymosin alpha-1through subcutaneous injection once a day for 15 d.20healthy individuals older than 65 years were selected as healthy group.The lymphocyte subsets of objects in groups were measured before and after treatment.Results Before treatment,the ratios of CD3^+,CD4^+,Th1,CD4^+/CD8^+,CD19^+,NK of the patients in control and treatment groups were significantly decreased and the ratios of Treg and CD8^+were significantly increased compared with healthy group(P〈0.05 or P〈0.01);the ratios of Th2 was mildly increased in the patients in various groups,but these parameters of the patients had no significant differences between control group and treatment group(P〉 0.05).After treatment,the ratios of CD3^+,CD4^+,and Th1 were significantly increased while the ratios of CD8^+was significantly decreased of the patients in treatment group compared with control group(P〈0.05 or P〈0.01);the ratios of CD4^+/CD8^+,CD19^+,and NK cells were mildly increased while the ratios of Th2 and Treg were mildly decreased of the patients in treatment group compared with control group,but there was no statistically difference(P〉0.05).Conclusion Compared with healthy aged persons,the lymphopenia and lymphocyte subsets imbalance exist in the elderly patients with severe sepsis.Thymosin alpha-1can regulate the quantity and proportion of lymphocyte subsets in the elderly patients with severe sepsis.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2015年第5期994-997,共4页 Journal of Jilin University:Medicine Edition
基金 北京市中医管理局中西医结合项目资助课题(2014-ZYJ01)
关键词 老年 脓毒症 淋巴细胞亚群 免疫调节 elder sepsis lymphocyte subsets immune modulation
  • 相关文献

参考文献13

  • 1Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immuno suppression: a common syndrome and new horizon for surgical intensive care [J]. Trauma Acute Care Surg, 2012, 72 (6): 1491-1501.
  • 2Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign., international guidelines for management of severe sepsis and septic shock [J]. Crit Care Med, 2008, 36 (1): 296-327.
  • 3WaD, Meydani SN. Age-associated change in immune and inflammatory responses: impact of vitamin E intervention [J]. J Leukoc Biol, 2008, 84 (4): 900-914.
  • 4Hotchkiss RS, Opal S. Immunotherapy for sepsis: a new approach against an ancient foe [J]. N Engl J Med, 2010, 363 (1): 87-89.
  • 5董宁,姚咏明,曹玉珏,贺立新,于燕,柴家科,盛志勇.大面积烧伤脓毒症患者T淋巴细胞免疫功能的改变及临床意义[J].中华烧伤杂志,2007,23(2):84-87. 被引量:14
  • 6Osuehowski MF, Welch K, Siddiqui J, et al, Circulationg eytokine /inhibitor profiles reshape the understanding of the sirs/ears continuum in sepsis and predict mortality E J ]. J Immunol, 2006, 177 (3)~ 1967-1974.
  • 7Huang LF, Yao Yin, Dong N, et al. Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study [J]. Crit Care, 2010, 14 (1)~ 1-10.
  • 8Fehervati Z, Sakaguchi S. CD4+ Treg and immune control [J]. J Clin Invest, 2004, 114 (9): 1209-1217.
  • 9邵敏,刘宝,王锦权,陶晓根,周树生,金魁,张翠萍.脓毒症患者辅助性T细胞17和CD4^+CD25^+调节性T细胞表达及血必净注射液的干预作用[J].中国危重病急救医学,2011,23(7):430-434. 被引量:36
  • 10Kumpf O, Schumann RR. Genetic variation in innate immunity pathways and their potential contribution to the SIRS/CARS debate~ Evidence from human studies and animal models I-J]. J Innate Immun, 2010, 2 (5): 381-394.

二级参考文献44

共引文献49

同被引文献18

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部